1. A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma. (2nd September 2017) Authors: Capasso, Cristian; Magarkar, Aniket; Cervera-Carrascon, Victor; Fusciello, Manlio; Feola, Sara; Muller, Martin; Garofalo, Mariangela; Kuryk, Lukasz; Tähtinen, Siri; Pastore, Lucio; Bunker, Alex; Cerullo, Vincenzo Journal: Oncoimmunology Issue: Volume 6:Number 9(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CD40L coding oncolytic adenovirus allows long-term survival of humanized mice receiving dendritic cell therapy. (3rd October 2018) Authors: Zafar, Sadia; Sorsa, Suvi; Siurala, Mikko; Hemminki, Otto; Havunen, Riikka; Cervera-Carrascon, Victor; Santos, João Manuel; Wang, Hongjie; Lieber, Andre; De Gruijl, Tanja; Kanerva, Anna; Hemminki, Akseli Journal: Oncoimmunology Issue: Volume 7:Number 10(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Constitutively active GSK3β as a means to bolster dendritic cell functionality in the face of tumour-mediated immune suppression. (3rd October 2019) Authors: López González, Marta; Oosterhoff, Dinja; Lindenberg, Jelle J.; Milenova, Ioanna; Lougheed, Sinead M.; Martiáñez, Tania; Dekker, Henk; Quixabeira, Dafne Carolina Alves; Hangalapura, Basav; Joore, Jos; Piersma, Sander R.; Cervera-Carrascon, Victor; Santos, Joao Manuel; Scheper, Rik J.; Verheul, He... Journal: Oncoimmunology Issue: Volume 8:Number 10(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Local delivery of interleukin 7 with an oncolytic adenovirus activates tumor-infiltrating lymphocytes and causes tumor regression. (31st December 2022) Authors: Kudling, Tatiana V.; Clubb, James H.A.; Quixabeira, Dafne C.A.; Santos, Joao M.; Havunen, Riikka; Kononov, Alexander; Heiniö, Camilla; Cervera-Carrascon, Victor; Pakola, Santeri; Basnet, Saru; Grönberg-Vähä-Koskela, Susanna; Arias, Victor; Gladwyn-Ng, Ivan; Aro, Katri; Bäck, Leif; Räsänen, Jari; ... Journal: Oncoimmunology Issue: Volume 11:Number 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Local therapy with an engineered oncolytic adenovirus enables antitumor response in non-injected melanoma tumors in mice treated with aPD-1. (31st December 2022) Authors: Quixabeira, Dafne C. A.; Cervera-Carrascon, Victor; Santos, Joao M.; Clubb, James H.A.; Kudling, Tatiana V.; Basnet, Saru; Heiniö, Camilla; Grönberg-Vähä-Koskela, Susanna; Anttila, Marjukka; Havunen, Riikka; Kanerva, Anna; Hemminki, Akseli Journal: Oncoimmunology Issue: Volume 11:Number 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivity. Issue 1 (13th January 2020) Authors: Santos, João Manuel; Heiniö, Camilla; Cervera-Carrascon, Victor; Quixabeira, Dafne C A; Siurala, Mikko; Havunen, Riikka; Butzow, Ralf; Zafar, Sadia; de Gruijl, Tanja; Lassus, Heini; Kanerva, Anna; Hemminki, Akseli Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Oncolytic adenoviruses: a game changer approach in the battle between cancer and the immune system. (4th May 2019) Authors: Cervera-Carrascon, Victor; Havunen, Riikka; Hemminki, Akseli Journal: Expert opinion on biological therapy Issue: Volume 19:Number 5(2019) Page Start: 443 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Tumor microenvironment remodeling by an engineered oncolytic adenovirus results in improved outcome from PD-L1 inhibition. (1st January 2020) Authors: Cervera-Carrascon, Victor; Quixabeira, Dafne C.A.; Santos, Joao Manuel; Havunen, Riikka; Zafar, Sadia; Hemminki, Otto; Heiniö, Camilla; Munaro, Eleonora; Siurala, Mikko; Sorsa, Suvi; Mirtti, Tuomas; Järvinen, Petrus; Mildh, Markus; Nisen, Harry; Rannikko, Antti; Anttila, Marjukka; Kanerva, Anna; ... Journal: Oncoimmunology Issue: Volume 9:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Tumor microenvironment remodeling by an engineered oncolytic adenovirus results in improved outcome from PD-L1 inhibition. (1st January 2020) Authors: Cervera-Carrascon, Victor; Quixabeira, Dafne C.A.; Santos, Joao Manuel; Havunen, Riikka; Zafar, Sadia; Hemminki, Otto; Heiniö, Camilla; Munaro, Eleonora; Siurala, Mikko; Sorsa, Suvi; Mirtti, Tuomas; Järvinen, Petrus; Mildh, Markus; Nisen, Harry; Rannikko, Antti; Anttila, Marjukka; Kanerva, Anna; ... Journal: Oncoimmunology Issue: Volume 9:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗